STOCK PLEDGE AGREEMENTStock Pledge Agreement • January 31st, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 31st, 2006 Company Industry JurisdictionThis Stock Pledge Agreement (this “Agreement”) is dated as of January 31, 2006 by and between Acura Pharmaceuticals, Inc., a New York corporation (the “Pledgor”), and Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as hereinafter defined (the “Agent”), for the benefit of the Lenders.
STOCK PLEDGE AGREEMENTStock Pledge Agreement • November 10th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2005 Company Industry JurisdictionThis Stock Pledge Agreement (this “Agreement”) is dated as of November 9, 2005 by and between Acura Pharmaceuticals, Inc., a New York corporation (the “Pledgor”), and Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as hereinafter defined (the “Agent”), for the benefit of the Lenders.
STOCK PLEDGE AGREEMENTStock Pledge Agreement • September 16th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2005 Company Industry JurisdictionThis Stock Pledge Agreement (this “Agreement”) is dated as of September 16, 2005 by and between Acura Pharmaceuticals, Inc., a New York corporation (the “Pledgor”), and Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as hereinafter defined (the “Agent”), for the benefit of the Lenders.
STOCK PLEDGE AGREEMENTStock Pledge Agreement • June 23rd, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 23rd, 2005 Company Industry JurisdictionThis Stock Pledge Agreement (this “Agreement”) is dated as of June 22, 2005 by and between Acura Pharmaceuticals, Inc., a New York corporation (the “Pledgor”), and Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as hereinafter defined (the “Agent”), for the benefit of the Lenders.